Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07608601 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Latent Tuberculosis Infection Screening Using QuantiFERON at Pre-Employment Assessment in Hospital Workers CHu Nice

StatusCompleted
PhaseNot specified
Started2024-04-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-01
notable
Study Status, Study Design, Eligibility, Contacts/Locations v1
Completed without a posted recruiting period
Primary completion confirmed: April 2026 (last estimated June 2026)
Primary completion dateestimated 2026-06-30→confirmed 2026-04-30
Completion dateestimated 2026-08-30→confirmed 2026-04-30
Start dateestimated 2026-06-01→confirmed 2024-04-01
Eligibility criteria-130 characters
[...] ed as part of pre-employment screening. Exclusion Criteria: Known history of active tuberculosis disease before employment. Previously known latent tuberculosis infection before employment. Incomplete or unusable occupational health records. Indeterm [...]
Study sitescontacts updated at 1 of 1 site
2026-05-20
minor
Original filing
This retrospective observational single-center study aims to evaluate the medical and occupational relevance of systematic screening for latent tuberculosis infection using QuantiFERON-TB Gold Plus during pre-employment occupational health assessment among hospital workers at the University Hospital of Nice. Data will be collected retrospectively from occupational health medical records, immunology laboratory results and, when necessary, data from specialized follow-up by the tuberculosis control center. The primary objective is to determine the proportion of positive QuantiFERON-TB Gold Plus tests at pre-employment screening. Secondary objectives are to identify factors associated with a positive test, to describe the practical consequences of screening, including chest X-ray, diagnosis of latent tuberculosis infection and initiation of preventive treatment, and to estimate the cost of systematic screening.
Trial Details
NCT Number NCT07608601
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Latent Tuberculosis Infection
Enrollment 1,185 participants
Start Date 2024-04-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-02